Lift&Co. Expo Logo_Purple Bkgd.png
Toronto Success: The Cannabis Industry Counts on Lift&Co. Expo
26 mai 2022 15h08 HE | Lift&Co. Expo
TORONTO, May 26, 2022 (GLOBE NEWSWIRE) -- via CannabisNewsWire -- Lift&Co. Expo, Canada’s no. 1 cannabis conference and trade show, hosted its latest event at the Metro Toronto Convention...
Open For Business: Optimi Completes First Grow of Psilocybin Mushrooms and Introduces Head of Cultivation
25 mai 2022 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, May 25, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
IRWIN NATURALS LOGO [NEW BRANDING].jpg
Irwin Naturals Completes Acquisition of Ketamine Health Centers
20 mai 2022 17h54 HE | Irwin Naturals
LOS ANGELES, May 20, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that, further to its press release of April 18, 2022,...
87520785_101152591495741_6497961433500745728_o.jpg
Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction
19 mai 2022 12h07 HE | Mycotopia Therapies Inc.
MIAMI and MAUI, Hawaii, May 19, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of...
ibn-iw-globe-2.png
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast featuring Eric Weisblum, CEO of Silo Pharma Inc.
18 mai 2022 08h17 HE | InvestorBrandNetwork (IBN)
LOS ANGELES, May 18, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
Image
neurocare Announces Entry Into Ketamine-Assisted Therapy Market Through Cooperation With Privatpraxis Dr. Scheib in Berlin
11 mai 2022 03h00 HE | neurocare group AG
MUNICH, May 11, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
22157.jpg
Global Psychedelic Drugs Market Analysis Report 2022 Featuring AstraZeneca, COMPASS, Klarisana, F. Hoffmann-La Roche, Takeda Pharma, Dr. Reddy's Laboratories, Pfizer, Merck & Co., & Lundbeck
06 mai 2022 06h18 HE | Research and Markets
Dublin, May 06, 2022 (GLOBE NEWSWIRE) -- The "Global Psychedelic Drugs Market Size & Share to 2027" report has been added to ResearchAndMarkets.com's offering. Increase in prevalence of...
Tripsitter
Psychedelic Media Company Tripsitter.com Announces Refresh for 2022 — Features Over 100 Psychedelic Monographs
03 mai 2022 21h00 HE | Tripsitter
NEW YORK, May 03, 2022 (GLOBE NEWSWIRE) -- Tripsitter (tripsitter.com) is an educational resource and advocate for the responsible use of psychedelics. The site features over 100 psychedelic...
87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market
02 mai 2022 08h30 HE | Mycotopia Therapies Inc.
MIAMI, May 02, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
The Promise of Psychedelics
New Book by Psychiatrist and Mental Health Advocate Launches - The Promise of Psychedelics
22 avr. 2022 11h31 HE | Ingenium Books (955172)
EDMONTON, Alberta, April 22, 2022 (GLOBE NEWSWIRE) -- Easy to read, yet backed by research, Dr. Peter Silverstone's new book, The Promise of Psychedelics: Science Based Hope for Better Mental...